Nitric oxide in normal and preeclamptic pregnancy

Current Pharmaceutical Biotechnology

Volumn 12, Issue 5, 2011, Pages 743-749

  Poniedzialek Czajkowska, Elzbieta ^a   Marciniak, Beata ^a   Kimber Trojnar, Zaneta ^a   Leszczyńska Gorzelak, Bozena ^a   Oleszczuk, Jan ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Arginine; Nitric oxide; Preeclampsia; Pregnancy

Indexed keywords

ARGININE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GUANYLATE CYCLASE; N(G),N(G) DIMETHYLARGININE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE DONOR;

ANGIOGENESIS; APOPTOSIS; ATHEROSCLEROSIS; BLOOD FLOW; BLOOD VESSEL REACTIVITY; BLOOD VESSEL TONE; CELL INVASION; DECIDUA; ENDOTHELIAL DYSFUNCTION; FETOPLACENTAL UNIT; HUMAN; HYPERTENSION; LEUKOCYTE ADHERENCE; MITOCHONDRION; MYOMETRIUM; OXYGEN CONSUMPTION; PLACENTA; PREECLAMPSIA; REGULATORY MECHANISM; REVIEW; THROMBOCYTE AGGREGATION; TROPHOBLAST; UTERUS; VASCULAR SMOOTH MUSCLE;

MAMMALIA;

EID: 79955590400     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920111795470921     Document Type: Review

References (87)

1. Cannon, R.O. 3rd. Role of nitric oxide in cardiovascular disease: focus on the endothelium. Clin. Chem., 1998, 44(8 Pt2), 1809-1819.
2. Knowles, R.G.; Moncada, S. Nitric oxide synthases in mammals. Biochem. J., 1994, 298(Pt2), 249-258.
3. Pagliaro, P. Differential biological effects of products of nitric oxide (NO) synthase: It is not enough to say NO. Life Sci., 2003, 73(17), 2137-2149.
4. Moncada, S.; Higgs, A. The L-arginine-nitric oxide pathway. N. Engl. J. Med., 1993, 329(27), 2002-2012.
5. Moncada, S.; Erusalimsky, J.D. Does nitric oxide modulate mitochondrial energy generation and apoptosis? Nat. Rev. Mol. Cell. Biol., 2002, 3(3), 214-220.
6. Ghafourifar, P.; Sen, C.K. Mitochondrial nitric oxide synthase. Front. Biosci., 2007, 12, 1072-1078.
7. Neri, I.; Blasi, I.; Facchinetti, F. Effects of acute L-arginine infusion on non-stress test in hypertensive pregnant women. J. Matern. Fetal Neonatal Med., 2004, 16(1), 23-26.
8. Germain, A.M.; Valdés, G.; Romanik, M.C.; Reyes, M.S. Evidence supporting a beneficial role for long-term L-arginine supplementation in high-risk pregnancies. Hypertension, 2004, 44(1), e1.
9. Jobgen, W.S.; Fried, S.K.; Fu, W. J; Meininger, C.J.; Wu, G. Regulatory role for the arginine-nitric oxide pathway in metabolism of energy substrates. J. Nutr. Biochem., 2006, 17(9), 571-588.
10. Montañez, R.; Rodríguez-Caso, C.; Sánchez-Jiménez, F.; Medina, M.A. In silico analysis of arginine catabolism as a source of nitric oxide or polyamines in endothelial cells. Amino Acids, 2008, 34(2), 223-229.
11. Alderton, W.K.; Cooper, C.E.; Knowles, R.G. Nitric oxide synthases: structure, function and inhibition. Biochem. J., 2001, 357(Pt3), 593-615.
12. Tóth, M. Role of tetrahydrobiopterin in the regulation of activity of human placental nitric oxide synthase in normal and pre-eclamptic pregnancies. Orv. Hetil., 2002, 143(8), 391-398.
13. Zweier, J. L.; Wang, P.; Samouilov, A.; Kuppusamy, P. Enzymeindependent formation of nitric oxide in biological tissues. Nat. Med., 1995, 1(8), 804-809.
14. Li, H.; Cui, H.; Kundu, T.K.; Alzawahra, W.; Zweier, J.L. Nitric oxide production from nitrite occurs primarily in tissues not in the blood: critical role of xanthine oxidase and aldehyde oxidase. J. Biol. Chem., 2008, 283(26), 17855-17863.
15. Wink, D.A.; Miranda, K.M.; Espey, M.G.; Pluta, R.M.; Hewett, S.J.; Colton, C.; Vitek, M.; Feelisch, M.; Grisham, M.B. Mechanisms of the antioxidant effects of nitric oxide. Antioxid. Redox Signal., 2001, 3(2), 203-213.
16. Struck, A.T.; Hogg, N.; Thomas, J.P.; Kalyanaraman, B. Nitric oxide donor compounds inhibit the toxicity of oxidized low-density lipoprotein to endothelial cells. FEBS Lett., 1995, 361(2-3), 291-294.
17. King, D.E.; Mainous, A.G. 3rd; Geesey, M.E. Variation in Larginine intake follow demographics and lifestyle factors that may impact cardiovascular disease risk. Nutr. Res., 2008, 28(1), 21-24.
18. Wu, G.; Knabe, D.A. Free and protein-bound amino acids in sow's colostrum and milk. J. Nutr., 1994, 124(3), 415-424.
19. Escobales, N.; Rivera-Correa, M.; Altieri, P.I.; Rodriguez, J.F. Relationship between NO synthesis, arginine transport, and intracellular arginine levels in vascular smooth muscle cells. Amino Acids, 2000, 19(2), 451-468.
20. Closs, E.I.; Scheld, J.S.; Sharafi, M.; Förstermann, U. Substrate supply for nitric oxide synthase in macrophages and endothelial cells: role of cationic amino acid transporters. Mol. Pharmacol., 2000, 57(1), 68-74.
21. McDonald, K.K.; Zharikov, S.; Block, E.R.; Kilberg, M.S. A caveolar complex between the cationic amino acid transporter 1 and endothelial nitric-oxide synthase may explain the "arginine paradox". J. Biol. Chem., 1997, 272(50), 31213-312316.
22. Schwartz, D.; Schwartz, I.F.; Gnessin, E.; Wollman, Y.; Chernichovsky, T.; Blum, M.; Iaina, A. Differential regulation of glomerular arginine transporters (CAT-1 and CAT-2) in lipopolysaccharide-treated rats. Am. J. Physiol. Renal Physiol., 2003, 284(4), F788-F795.
23. Schwartz, I.F.; Ayalon, R.; Chernichovski, T.; Reshef, R.; Chernin, G.; Weinstein, T.; Litvak, A.; Levo, Y.; Schwartz, D. Arginine uptake is attenuated through modulation of cationic amino-acid transporter-1, in uremic rats. Kidney Int., 2006, 69(2), 298-303.
24. Schwartz, I.F.; Iaina, A.; Benedict, Y.; Wollman, Y.; Chernichovski, T.; Brasowski, E.; Misonzhnik, F.; Ben-Dor, A.; Blum, M.; Levo, Y.; Schwartz, D. Augmented arginine uptake, through modulation of cationic amino acid transporter-1, increases GFR in diabetic rats. Kidney Int., 2004, 65(4), 1311-1319.
25. Ayuk, P.T.; Sibley, C.P.; Donnai, P.; D'Souza, S.; Glazier, J.D. Development and polarization of cationic amino acid transporters and regulators in the human placenta. Am. J. Physiol. Cell Physiol., 2000, 278(6), C1162-C1171.
26. Noris, M.; Todeschini, M.; Cassis, P.; Pasta, F.; Cappellini, A.; Bonazzola, S.; Macconi, D.; Maucci, R.; Porrati, F.; Benigni, A.; Picciolo, C.; Remuzzi, G. L-arginine depletion in preeclampsia orients nitric oxide synthase toward oxidant species. Hypertension, 2004, 43(3), 614-622.
27. Stuehr, D.; Pou, S.; Rosen, G.M. Oxygen reduction by nitric-oxide synthases. J. Biol. Chem., 2001, 276(18), 14533-14536.
28. Leiper, J.; Vallance, P. Biological significance of endogenous methylarginines that inhibit nitric oxide synthases. Cardiovasc. Res., 1999, 43(3), 542-548.
29. Savvidou, M.D.; Hingorani, A.D.; Tsikas, D.; Frölich, J.C.; Vallance, P.; Nicolaides, K.H. Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia. Lancet, 2003, 361(9368), 1511-1517.
30. Chwalisz, K.; Garfield, R.E. Role of nitric oxide in implantation and menstruation. Hum. Reprod,. 2000, 15(Suppl. 3), 96-111.
31. Hishikawa, K.; Nakaki, T.; Marumo, T.; Suzuki, H.; Kato, R.; Saruta, T. Up-regulation of nitric oxide synthase by estradiol in human aortic endothelial cells. FEBS Lett., 1995, 360(3), 291-293.
32. Reshef, R.; Schwartz, D.; Ingbir, M.; Shtabsky, A.; Chernichovski, T.; Isserlin, B.A.; Chernin, G.; Levo, Y.; Schwartz I.F. A profound decrease in maternal arginine uptake provokes endothelial nitration in the pregnant rat. Am. J. Physiol. Heart Circ. Physiol., 2008, 294(3), H1156-H1163.
33. Cadnapaphornchai, M.A.; Ohara, M.; Morris, K.G. Jr; Knotek, M.; Rogachev, B.; Ladtkow, T.; Carter, E.P.; Schrier, R.W. Chronic NOS inhibition reverses systemic vasodilation and glomerular hyperfiltration in pregnancy. Am. J. Physiol. Renal Physiol., 2001, 280(4), F592-F598.
34. Conrad, K.P.; Joffe, G.M.; Kruszyna, H.; Kruszyna, R.; Rochelle, L.G.; Smith, R.P.; Chavez, J.E.; Mosher, M.D. Identification of increased nitric oxide biosynthesis during pregnancy in rats. FASEB J., 1993, 7(6), 566-571.
35. Sullivan, J.A.; Grummer, M.A.; Yi, F.X.; Bird, I.M. Pregnancyenhanced endothelial nitric oxide synthase (eNOS) activation in uterine artery endothelial cells shows altered sensitivity to Ca2+, U0126, and wortmannin but not LY294002-evidence that pregnancy adaptation of eNOS activation occurs at multiple levels of cell signaling. Endocrinology, 2006, 147(5), 2442-2457.
36. Conrad, K.P.; Kerchner, L.J.; Mosher, M.D. Plasma and 24-h NO(x) and cGMP during normal pregnancy and preeclampsia in women on a reduced NO(x) diet. Am. J. Physiol.,1999, 277(1 Pt2), F48-F57.
37. Buxton, I.L. Regulation of uterine function: a biochemical conundrum in the regulation of smooth muscle relaxation. Mol. Pharmacol., 2004, 65(5), 1051-1059.
38. Tichenor, S. D; Malmquist, N.A.; Buxton, I.L. Dissociation of cGMP accumulation and relaxation in myometrial smooth muscle: effects of S-nitroso-N-acetylpenicillamine and 3-morpholinosyndonimine. Cell. Signal., 2003, 15(8), 763-772.
39. Baylis, C.; Beinder, E.; Sütö, T.; August, P. Recent insights into the roles of nitric oxide and renin-angiotensin in the pathophysiology of preeclamptic pregnancy. Semin. Nephrol., 1998, 18(2), 208-230.
40. Conrad, K.P.; Vill, M.; McGuire, P.G.; Dail, W.G.; Davis, A.K. Expression of nitric oxide synthase by syncytiotrophoblast in human placental villi. FASEB J., 1993, 7(13), 1269-1276.
41. Zhou, Y.; Fisher, S.J.; Janatpour, M.; Genbacev, O.; Dejana, E.; Wheelock, M.; Damsky, C.H. Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion? J. Clin. Invest., 1997, 99(9), 2139-2151.
42. Craven, C.M.; Morgan, T.; Ward, K. Decidual spiral artery remodelling begins before cellular interaction with cytotrophoblasts. Placenta, 1998, 19(4), 241-252.
43. Lyall, F.; Bulmer, J.N.; Kelly, H.; Duffie, E.; Robson, S.C. Human trophoblast invasion and spiral artery transformation: the role of nitric oxide. Am. J. Pathol., 1999, 154(4), 1105-1114.
44. Martin, D.; Conrad, K.P. Expression of endothelial nitric oxide synthase by extravillous trophoblast cells in the human placenta. Placenta, 2000, 21(1), 23-31.
45. Bamberger, A.M.; Koglin, M.; Kempfert, J.; Löning, T.; Scholz, H.; Behrends, S. Expression and tissue localization of soluble guanylyl cyclase in the human placenta using novel antibodies directed against the alpha(2) subunit. J. Clin. Endocrinol. Metab., 2001, 86(2), 909-912.
46. Kaufmann, P.; Black, S.; Huppertz, B. Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol. Reprod., 2003, 69(1), 1-7.
47. Al-Hijji, J.; Andolf, E.; Laurini, R.; Batra, S. Nitric oxide synthase activity in human trophoblast, term placenta and pregnant myometrium. Reprod. Biol. Endocrinol., 2003, 1, 51.
48. Valdes, G.; Kaufmann, P.; Corthorn, J.; Erices, R.; Brosnihan, K.B.; Joyner-Grantham, J. Vasodilator factors in the systemic and local adaptations to pregnancy. Reprod. Biol. Endocrinol, 2009, 7, 79.
49. Novaro, V.; Colman-Lerner, A.; Ortega, F.V.; Jawerbaum, A.; Paz, D.; Lo Nostro, F.; Pustovrh, C.; Gimeno, M.F.; González, E. Regulation of metalloproteinases by nitric oxide in human trophoblast cells in culture. Reprod. Fertil. Dev., 2001, 13(5-6), 411-420.
50. Shizukuda, Y.; Tang, S.; Yokota, R.; Ware, J.A. Vascular endothelial growth factor-induced endothelial cell migration and proliferation depend on a nitric oxide-mediated decrease in protein kinase Cdelta activity. Circ. Res., 1999, 85(3), 247-256.
51. Babaei, S.; Stewart, D.J. Overexpression of endothelial NO synthase induces angiogenesis in a co-culture model. Cardiovasc. Res., 2002, 55(1), 190-200.
52. Dash, P.R.; Cartwright, J.E.; Baker, P.N.; Johnstone, A.P.; Whitley, G.S. Nitric oxide protects human extravillous trophoblast cells from apoptosis by a cyclic GMP-dependent mechanism and independently of caspase 3 nitrosylation. Exp. Cell. Res., 2003, 287(2), 314-324.
53. Roh, C.R.; Heo, J.H.; Yang, S.H.; Bae, D.S. Regulation of connexin 43 by nitric oxide in primary uterine myocytes from term pregnant women. Am. J. Obstet. Gynecol., 2002, 187(2), 434-440.
54. Rossmanith, W.G.; Hoffmeister, U.; Wolfahrt, S.; Kleine, B.; McLean, M.; Jacobs, R.A.; Grossman, A.B. Expression and functional analysis of endothelial nitric oxide synthase (eNOS) in human placenta. Mol. Hum. Reprod., 1999, 5(5), 487-494.
55. Kiss, H.; Schneeberger, C.; Tschugguel, W.; Lass, H.; Huber, J.C.; Husslein, P.; Knöfler, M. Expression of endothelial (type III) nitric oxide synthase in cytotrophoblastic cell lines: regulation by hypoxia and inflammatory cytokines. Placenta, 1998, 19(8), 603-611.
56. Connelly, L.; Madhani, M.; Hobbs, A.J. Resistance to endotoxic shock in endothelial nitric-oxide synthase (eNOS) knock-out mice: a pro-inflammatory role for eNOS-derived no in vivo. J. Biol. Chem., 2005, 280(11), 10040-10046.
57. Zimmermann, K.; Opitz, N.; Dedio, J.; Renne, C.; Muller-Esterl, W.; Oess, S. NOSTRIN: a protein modulating nitric oxide release and subcellular distribution of endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. USA, 2002, 99(26), 17167-17172.
58. Icking, A.; Matt, S.; Opitz, N.; Wiesenthal, A.; Müller-Esterl, W.; Schilling, K. NOSTRIN functions as a homotrimeric adaptor protein facilitating internalization of eNOS. J. Cell Sci., 2005, 118(Pt21), 5059-5069.
59. Speake, P.F.; Glazier, J.D.; Ayuk, P.T.; Reade, M.; Sibley, C.P.; D'Souza, S.W. L-Arginine transport across the basal plasma membrane of the syncytiotrophoblast of the human placenta from normal and preeclamptic pregnancies. J. Clin. Endocrinol. Metab., 2003, 88(9), 4287-4292.
60. Conrad K.P. Possible mechanisms for changes in renal hemodynamics during pregnancy: studies from animal models. Am. J. Kidney Dis., 1987, 9(4), 253-259.
61. Grillo, M.A.; Lanza, A.; Colombatto, S. Transport of amino acids through the placenta and their role. Amino Acids, 2008, 34(4), 517-523.
62. Myatt, L.; Brockman, D.E.; Eis, A.L.; Pollock, J.S. Immunohistochemical localization of nitric oxide synthase in the human placenta. Placenta, 1993, 14(5), 487-495.
63. Battaglia, F.C.; Regnault, T.R. Placental transport and metabolism of amino acids. Placenta, 2001, 22(2-3), 145-161.
64. Ayuk, P.T.; Theophanous, D.; D'Souza, S.W.; Sibley, C.P.; Glazier, J.D. L-arginine transport by the microvillous plasma membrane of the syncytiotrophoblast from human placenta in relation to nitric oxide production: effects of gestation, preeclampsia, and intrauterine growth restriction. J. Clin. Endocrinol. Metab., 2002, 87(2), 747-751.
65. Lyall, F.; Greer, I.A.; Young, A.; Myatt, L. Nitric oxide concentrations are increased in the feto-placental circulation in intrauterine growth restriction. Placenta, 1996, 17(2-3), 165-168.
66. Lyall, F.; Young, A.; Greer, I.A. Nitric oxide concentrations are increased in the fetoplacental circulation in preeclampsia. Am. J. Obstet. Gynecol., 1995, 173(3 Pt1), 714-718.
67. King, R.G.; Gude, N.M.; Di Iulio, J.L.; Brennecke, S.P. Regulation of human placental fetal vessel tone: role of nitric oxide. Reprod. Fertil. Dev., 1995, 7(6), 1407-1411.
68. Salas, S.P. Role of nitric oxide in maternal hemodynamics and hormonal changes in pregnant rats. Biol. Res., 1998, 31(3), 243-250.
69. Yallampalli, C.; Garfield, R.E. Inhibition of nitric oxide synthesis in rats during pregnancy produces signs similar to those of preeclampsia. Am. J. Obstet. Gynecol., 1993, 169(5), 1316-1320.
70. Lowe, D.T. Nitric oxide dysfunction in the pathophysiology of preeclampsia. Nitric Oxide, 2000, 4(4), 441-458.
71. Sooranna, S.R.; Morris, N.H.; Steer, P.J. Placental nitric oxide metabolism. Reprod. Fertil. Dev., 1995, 7(6), 1525-1531.
72. Brennecke, S.P.; Gude, N.M.; Di Iulio, J.L.; King, R.G. Reduction of placental nitric oxide synthase activity in pre-eclampsia. Clin. Sci., (Lond.) 1997, 93(1), 51-55.
73. Beinder, E.; Mohaupt, M.G.; Schlembach, D.; Fischer, T.; Sterzel, R.B.; Lang, N.; Baylis, C. Nitric oxide synthase activity and Doppler parameters in the fetoplacental and uteroplacental circulation in preeclampsia. Hypertens. Pregnancy, 1999, 18(2), 115-127.
74. Karteris, E.; Vatish, M.; Hillhouse, E.W.; Grammatopoulos, D.K. Preeclampsia is associated with impaired regulation of the placental nitric oxide-cyclic guanosine monophosphate pathway by corticotropin-releasing hormone (CRH) and CRH-related peptides. J. Clin. Endocrinol. Metab., 2005, 90(6), 3680-3687.
75. Xia, Y.; Dawson, V.L.; Dawson, T.M.; Snyder, S.H.; Zweier, J.L. Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. Proc. Natl. Acad. Sci. USA, 1996, 93(13), 6770-6774.
76. Vásquez-Vivar, J.; Kalyanaraman, B.; Martásek, P.; Hogg, N.; Masters, B.S.; Karoui, H.; Tordo, P.; Pritchard, K.A. Jr. Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc. Natl. Acad. Sci. USA, 1998, 95(16), 9220-9225.
77. McCormick, C.C.; Li, W.P.; Calero, M. Oxygen tension limits nitric oxide synthesis by activated macrophages. Biochem. J., 2000, 350 Pt3, 709-716.
78. Many, A.; Hubel, C.A.; Fisher, S.J.; Roberts, J.M.; Zhou, Y. Invasive cytotrophoblasts manifest evidence of oxidative stress in preeclampsia. Am. J. Pathol., 2000, 156(1), 321-331.
79. Whorton, A.R.; Simonds, D.B.; Piantadosi, C.A. Regulation of nitric oxide synthesis by oxygen in vascular endothelial cells. Am. J. Physiol., 1997, 272(6 Pt1), L1161-L1166.
80. Beckman, J.S.; Koppenol, W.H. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am. J. Physiol., 1996, 271(5 Pt1), C1424-C1437.
81. Norris, L.A.; Higgins, J.R.; Darling, M.R.; Walshe, J.J.; Bonnar, J. Nitric oxide in the uteroplacental, fetoplacental, and peripheral circulations in preeclampsia. Obstet. Gynecol., 1999, 93(6), 958-963.
82. Neri, I.; Mazza, V.; Galassi, M.C.; Volpe, A.; Facchinetti, F. Effects of L-arginine on utero-placental circulation in growthretarded fetuses. Acta Obstet. Gynecol. Scand., 1996, 75(3), 208-212.
83. Neri, I.; Jasonni, V.M.; Gori, G.F.; Blasi, I.; Facchinetti, F. Effect of L-arginine on blood pressure in pregnancy-induced hypertension: a randomized placebo-controlled trial. J. Matern. Fetal Neonatal Med., 2006, 19(5), 277-281.
84. Rytlewski, K.; Olszanecki, R.; Korbut, R.; Zdebski, Z. Effects of prolonged oral supplementation with l-arginine on blood pressure and nitric oxide synthesis in preeclampsia. Eur. J. Clin. Invest., 2005, 35(1), 32-37.
85. Belkacemi, L.; Bainbridge, S.A.; Dickinson, M.A.; Smith, G. N; Graham, C.H. Glyceryl trinitrate inhibits hypoxia/reoxygenationinduced apoptosis in the syncytiotrophoblast of the human pla centa: therapeutic implications for preeclampsia. Am. J. Pathol., 2007, 170(3), 909-920.
86. Meher, S.; Duley, L. Nitric oxide for preventing pre-eclampsia and its complications. Cochrane Database Syst. Rev., 2007, 18(2), CD006490.
87. de Pace, V.; Chiossi, G.; Facchinetti, F. Clinical use of nitric oxide donors and L-arginine in obstetrics. J. Matern. Fetal Neonatal Med., 2007, 20(8), 569-579.